1315 Capital
Overview
1315 Capital provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare services companies, the latter including businesses focused on cost containment and digital health. We believe that these investment areas are attractive largely due to numerous niche market sub-segments and business models where high-quality management teams can rapidly grow small platform companies, in a capital efficient way, into large and important businesses. The firm targets $10-$30 million investments in commercial healthcare entities that have the potential to scale to approximately $100 million of revenue, a highly attractive level for acquisition or to access the public markets.\\In addition to experienced investing partners, 1315 Capital leverages an operating partner model of CEO and "Right Hand" COO Executive, a partnership that works together to navigate diligence, drive decisions, and achieve premium exits. Three operating teams contribute their collective experience to 1315 Capital in the areas of specialty pharmaceuticals, medical technologies and healthcare services. These three teams have built companies from expansion and growth phases to entities with revenues in excess of $100 million, resulting in almost $5 billion of aggregate exit value.
Investment Focus
- Commercial-stage healthcare companies with significant growth potential
Portfolio Companies
Reach 1315 Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about 1315 Capital
What sectors does 1315 Capital invest in?
1315 Capital invests in Healthcare Services, Pharmaceuticals, Medical Technology and Health & Wellness, and is based in Philadelphia, Pennsylvania, United States. 1315 Capital is listed as a private equity in the ConnectSafely investor database.
What stage does 1315 Capital invest at?
1315 Capital backs companies at Growth and Buyout, writing cheques of 5M - 50M.
Which regions does 1315 Capital invest in?
1315 Capital invests across United States.
Who are the partners at 1315 Capital?
Team members listed for 1315 Capital include Michael Koby (Co-Founder & Partner) and Brian Schwenk (CFO).
What companies has 1315 Capital invested in?
1315 Capital's portfolio includes Codis, Onkos Surgical, Colorescience, Centurion Service Group, Biocoat and Reaction Biology.
How do I contact 1315 Capital?
1315 Capital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
